Milo Vapes Global (MVG) has announced plans to launch two branded flavored tobacco products in the fall of 2022, with distribution limited to the Middle East region.
According to the Global State of Tobacco Harm Reduction (GSTHR), the number of smokers in the Middle East currently stands at 85 million and is expected to reach 100 million by 2025. The average smoking rate in the Middle East is 31.2%, with Jordan having the highest rate at 41.1%, followed by Lebanon at 31.8%. On the other hand, Morocco and Qatar have the lowest smoking rates at 13.8% and 13.1%, respectively.
A study published in the Journal of Tobacco Control in 2021 estimated that the six Gulf Cooperation Council countries - Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates - have a total smoking-related health cost exceeding $14.3 billion. In 2016 alone, government spending on smoking-related illnesses accounted for nearly 75% of the total cost. The Gulf Cooperation Council country with the largest population, Saudi Arabia, has the highest smoking-related economic cost, exceeding $6.3 billion.
We have selected and developed new innovative tobacco products that meet the preferences and desires of consumers, taking into account historical and cultural influences. Our company is committed to improving the quality of life for smokers by providing new tobacco products aimed at addressing smoking-related health issues," said Mike Khalil, President and Founder of MVG.
The electronic cigarette market is expected to grow at a rate of 9.7% annually, reaching $485 million by 2025, up from $267.9 million in 2018. The expected growth is attributed to an increase in the young population and the influence of media and e-cigarette companies. "Our company's goal is to contribute to the growth of the e-cigarette market through innovation, brand awareness, and our harm reduction program," Mr. Khalil said.
The government has an important role to play in changing people's smoking behavior. It must regulate and supervise the electronic cigarette industry in each country, and the health department should protect both the electronic cigarette industry and consumers by ensuring the safety and integrity of these products. In addition, healthcare providers should recommend that smoking patients transition to less harmful alternatives, such as electronic cigarettes, through healthcare policies and disease prevention plans. Mr. Harileh concluded.
Statement:
This article is a compilation of third-party information for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the content. The compilation of this article is only intended for industry exchange and research.
Due to limitations in our levels of translation, the translated articles may not fully reflect the original text. Therefore, it is advised that you refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic issues, as well as those related to Hong Kong, Macau, Taiwan, and foreign affairs.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to have it deleted.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
